Drugs / BCG vaccine InterVax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02692963 | Apr → Oct 2016 | Plasmodium falciparum malaria | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG vaccine InterVax | “BCG vaccine InterVax” NCT02692963 ↗ |
| Modality | Vaccine | “BCG vaccine, a live attenuated Mycobacterium bovis vaccine” NCT02692963 ↗ |